Abstract:Background: Unc-51-like kinases 1 (ULK1) plays an important role in the development of tumors but its roles remains largely unknown. The clinical and biological significance of ULK1 in colon cancer remains unclear.Methods: The expression ULK1 were initially assessed by meta‑analysis in the Oncomine database and TCGA analysis, followed by the validations in two independent colon cancer patient cohorts. A functional characterization of ULK1 in colon cancer was examined by targeted gene silencing in colon cancer cell lines and a xenograft animal model. Transcriptome analysis was used to explore the genetic changes in the transcriptome of ULK1 silencing.Findings: Meta-analysis revealed that increased ULK1 mRNA expression was associated with colon cancer as compared with the normal colon tissues. In our original cohort of colon cancer patients, ULK1 was also upregulated significantly in colon cancer and was significantly associated with tumor size and invasion depth as well as worse overall survival. Further multivariate analysis showed that ULK1 expression remained an independent prognostic factor for survival. Knockdown of ULK1 led to suppressed proliferation in colon cancer cell lines, as well as in the xenograft animal model. The transcriptome analysis showed that inhibition of ULK1 significantly changes the expression of the genes relate to ErbB signaling pathway. Further studies demonstrate that inactivation of ULK1 significantly decrease EGFR levels in vivo and in vitro.Interpretation: These observations strongly indicate a novel evidence for the oncogenic role of ULK1 and suggest that it can serve as a useful marker for the prognosis of colon cancer and an oncogenic EGFR regulator in the development of colon cancer.Funding Statement: This work was supported by the National Natural Science Foundation of China (No. 81802640, 31770860, 81572589, 81602560), the Natural Science Foundation of Fujian Province (2018J01400, 2018R1101), the Health and young middle-aged of personnel training project funding of Fujian Province (2016-ZQN-89) and Scientific Research Projects for Overseas Students in Xiamen City.Declaration of Interests: The authors declare no conflict of interests.Ethics Approval Statement: All animals were performed in accordance with a protocol approved by the Animal Care and Use Committee of Xiamen University. This study was approved by the Medical Ethics Committee of Zhongshan Hospital Affiliated to Xiamen University in accordance with the Helsinki Declaration and conducted with the informed consent of all patients.

CK1δ/ε inhibition induces ULK1-mediated autophagy in tumorigenesis

CK1α suppresses lung tumour growth by stabilizing PTEN and inducing autophagy

Effects of Altered Expression and Activity Levels of CK1δ and Ɛ on Tumor Growth and Survival of Colorectal Cancer Patients

UNC51-like kinase 1, autophagic regulator and cancer therapeutic target.

CK1δ Activity is Modulated by CDK2/E- and CDK5/p35-mediated Phosphorylation

Ulk1 Can Suppress Or Promote Tumor Growth Under Different Conditions

ULK1 Depletion Protects Mice from Diethylnitrosamine-Induced Hepatocarcinogenesis by Promoting Apoptosis and Inhibiting Autophagy

KNOCKDOWN OF CASEIN KINASE 1e INHIBITS CELL PROLIFERATION AND INVASION OF COLORECTAL CANCER CELLS VIA INHIBITION OF THE Wnt/β-CATENIN SIGNALING.

Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo

CDK1 phosphorylates ULK1-ATG13 complex to regulate mitotic autophagy and Taxol chemosensitivity

Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells

New Tumor Suppressor Cxxc Finger Protein 4 Inactivates Mitogen Activated Protein Kinase Signaling

KNOCKDOWN OF CASEIN KINASE le INHIBITS CELL PROLIFERATION AND INVASION OF COLORECTAL CANCER CELLS VIA INHIBITION OF THE Wnt/beta-CATENIN SIGNALING

The mechanism of UNC-51-like kinase 1 and the applications of small molecule modulators in cancer treatment

ULK1-ATG13 and Their Mitotic Phospho-Regulation by CDK1 Connect Autophagy to Cell Cycle

Serine/Threonine Kinase Unc-51-like Kinase-1 (ulk1) Phosphorylates the Co-chaperone Cell Division Cycle Protein 37 (cdc37) and Thereby Disrupts the Stability of Cdc37 Client Proteins

An autophagy-independent role of ULK1/ULK2 in mechanotransduction and breast cancer cell migration

ULK1 is Associated with Poor Prognosis and Functions As an Oncogenic EGFR Regulator in the Development of Colon Cancer

A Review of ULK1-Mediated Autophagy in Drug Resistance of Cancer

Phospho-regulation and function of ULK1-ATG13 during the cell cycle

SBI0206965, a Novel Inhibitor of Ulk1, Suppresses Non-Small Cell Lung Cancer Cell Growth by Modulating Both Autophagy and Apoptosis Pathways.